HIF1A and breast cancer: In a different study, the extended use of dimethyl-2-ketoglutarate (DKG), a cell membrane-permeable α-KG analogue that stabilizes HIF-1α, could reprogram breast cancer cells to acquire stem-like characteristics [94].